Clinical trials
Recruiting Phase 3 Alzheimer Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 13 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 6 |
| Eli Lilly and Company | 3 |
| Hoffmann-La Roche | 2 |
| JYAMS PET Research & Development Limited | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Bigespas LTD | 1 |
| CereMark Pharma, LLC | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
| I.R.C.C.S. Fondazione Santa Lucia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 30 |
| Dementia | 6 |
| Cognitive Dysfunction | 5 |
| Psychomotor Agitation | 3 |
| Psychotic Disorders | 2 |
| Amyloid Neuropathies, Familial | 1 |
| Amyloidosis | 1 |
| Cardiomyopathies | 1 |
| Chronic Pain | 1 |
| Chronic Traumatic Encephalopathy | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.